A multicenter randomized study to evaluate intracoronary abciximab with the ClearWay catheter to improve outcomes with Lysis (IC ClearLy): trial study design and rationale.

Download in:

• JSON
• RDF
• N3/Turtle
• N-Triples

View as

• Triples